Highly Selective Inhibitor Library

目录号 L3500

A unique collection of 295 validated bioactive compounds covering over 119 targets.

サイズ 価格(税別)  
予めDMSOに溶解しています
741720.19
1366108.13
ご連絡ください

お気に入りの分子或いは調達サービスにより、分子ライブラリーをカスタマイズします。
お客様自身のニーズを満たすために、弊社の製品を数量、状態（乾燥状態/固体或いはDMSO）等で選択できます。

Highly Selective Inhibitor Library内容

Download theHighly Selective Inhibitor Library - SDF
Download theHighly Selective Inhibitor Library - XLSX

製品特性＆メリット

・生物活性が確認されている、295種類のターゲット選択化合物ライブラリーです。

・それぞれの化合物はターゲット分子との相互作用能に基づいて選別されています。そのため、オフ・ターゲット作用は最小限に抑えられています。

・非メインターゲットに比べて選択性は100倍以上高いです。

・PI3K/Akt、MAPK、PTK、JAK、アポトーシスなど広範な経路を標的にしています。

・ターゲット分子を選別するためのツールとなります。

・構造的に多様で、薬効および細胞透過性が確認されています。

・詳しい構造説明と、お客様からのレビューなど豊富な情報があります。

・NMRとHPLC検査で製品の高純度を保証しています。

製品詳細情報

調合： 295種ターゲットセレクティブ阻害剤の集めは予めDMSO溶液に溶解します
ケース： 96/384 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
安定性： in DMSO
in DMSO
出荷方式： ブルーアイス物流
包装： 不活性ガス（Inert gas）

Highly Selective Inhibitor Library组成

HTS パートナ

他のライブラリー

  • FDA-approved Drug Library

    A unique collection of 2492 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS).

  • Drug Repurposing Library

    A unique collection of 2734 drugs that are marketed around the world or that have passed phase 1 clinical trials for high throughput screening (HTS) and high content screening (HCS).

  • Preclinical and Clinical Compound Library

    A unique collection of 2483 preclinical and clinical compounds for high throughput screening (HTS) and high content screening (HCS).

  • Bioactive Compound Library-I

    A unique collection of 5161 bioactive chemical compounds for high throughput screening (HTS) and high content screening (HCS).

  • Bioactive Compound Library-Ⅱ（Provided by Pfizer）

    A unique collection of 6716 bioactive chemical compounds（From Pfizer） for high throughput screening (HTS) and high content screening (HCS).

  • Kinase Inhibitor Library

    A unique collection of 806 kinase inhibitors for high throughput screening (HTS) and high content screening (HCS).

  • Express-Pick Library (Provided by Pfizer)

    A unique collection of 3924 chemical compounds featured different core structures and structural diversities respectively for high throughput screening (HTS) and high content screening (HCS).

  • Natural Product Library

    A unique collection of 2088 natural products for high throughput screening (HTS) and high content screening (HCS).

  • Human Endogenous Metabolite Library

    394 small collections of human cell metabolites, involving multiple metabolic pathways, which can be used for high-throughput screening, opening up new ways for humans to treat various diseases such as tumors.

  • Angiogenesis Related compound Library

    A unique collection of 110 small molecules used for angiogenesis research targeting Bcr-Abl,BTK,HIF,VEGFR,FGFR,FAK, etc.

  • Anti-alzheimer's Disease Compound Library

    A unique collection of 480 small molecules for exploring the mechanism of Alzheimer's disease.

  • Antibiotics Library

    A unique collection of 302 antibiotics used for anti-infetion research in order to identify drug target and open up new mechanism and ways to treat human disease.

  • Anti-cancer Compound Library

    A unique collection of 1842 anti-cancer small molecules for 12 types of cancers: Breast Cancer, Leukemia, Lung Cancer, Lymphoma, etc.

  • Anti-cancer Metabolism Compound Library

    A unique collection of 189 small molecules for cancer metabolism research.

  • Anti-diabetic Compound Library

    A unique collection of 143 small molecules affecting the development of diabetes.

  • Anti-infection Compound Library

    A unique collection of 911 anti-infective small molecules with biological activity of antibiotics,antifungal drugs,anti-HIV,etc.

  • Apoptosis Compound Library

    A unique collection of 670 small molecules used for apoptosis research targeting Bcl-2,Caspase,p53,TNF-alpha,Mdm2,survivin, etc.

  • Autophagy Compound Library

    A unique collection of 787 small molecules with autophagy-inducing or autophagy-inhibiting activity.

  • Cambridge Cancer Compound Library

    A unique collection of 230 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS).

  • Cell Cycle compound library

    A unique collection of 116 small molecule compounds used for cell cycle and related diseases research

  • CNS-Penetrant Compound Library

    A unique collection of 302 CNS-Penetrant compounds with biological activity for neurologic research.

  • Covalent Inhibitor Library

    A unique collection of 74 covalent Inhibitors for high throughput screening (HTS) and high content screening (HCS).

  • DNA Damage/DNA Repair compound Library

    A unique collection of 175 small molecules used for DNA Damage and Repair research targeting PARP,ATM/ATR,Topoisomerase,DNA/RNA Synthesis etc.

  • Epigenetics Compound Library

    Selleck Epigenetic inhibitor Library contains various small molecule modulators (inhibitors and activators) with biological activity used for epigenetic research and associated assays.

  • Fragment Library

    A unique collection of 939 Fragment compounds for Fragment-Based Drug Discovery (FBDD).

  • GPCR Compound Library

    Selleck GPCR Small Molecule Compound Library contains various small molecules targeting G protein coupled receptors with biological activity.

  • Histone modification compound library

    A unique collection of 108 compounds with biological activity used for histone modification research and associated assays

  • HTS Library for Drug Discovery (Provided by Pfizer)

    A unique collection of 80000 unpatented compounds features numerous structurally diverse compounds and several alternate compositions.

  • Immunology/Inflammation Compound Library

    A unique collection of 1065 small molecules modulators (inhibitors and activators) with biological activity used for Immunology/Inflammation research and associated assays.

  • Inhibitor Library

    A unique collection of 2601 inhibitors for high throughput screening (HTS) and high content screening (HCS).

  • Ion Channel Ligand Library

    A unique collection of 227 small molecule modulators used for Ion channel research.

  • JAK/STAT compound library

    A unique collection of 40 small molecules used for research in JAK-STAT signaling pathway.

  • MAPK Inhibitor Library

    A unique collection of 89 small molecule inhibitors used for MAPK signaling research.

  • Metabolism Compound Library

    A unique collection of 1213 small molecules with biological activity in numerous metabolic pathway: glycometabolism, lipid metabolism, proteolysis, etc.

  • Neuronal Signaling Compound Library

    A unique collection of 1095 small molecule compounds with biological activity used for neurologic research and associated assays

  • NF-κB Signaling Compound Library

    A unique collection of 37 small molecules used for NF-κB Signaling pathway research which plays a key role in immunology/inflammation and cancer.

  • PI3K/Akt Inhibitor Library

    A unique collection of 167 small molecule inhibitors used for PI3K/Akt/mTOR pathway research.

  • Protease Inhibitor Library

    A unique collection of 216 small molecule inhibitors used for chemical genomics, high-throughput screening (HTS), and high content screening (HCS).

  • Small Molecule Immuno-Oncology Compound Library

    A unique collection of 37 Immuno-Oncology small molecules used for oncotherapy in conjunction with other drugs.

  • Stem Cell Signaling Compound Library

    A unique collection of 267 compounds with biological activity used for stem cell regulatory and signaling pathway research.

  • TGF-beta/Smad compound library

    A unique collection of 28 small molecules with biological activity used for TGF-beta/Smad pathway research.

  • Tyrosine Kinase Inhibitor Library

    Tyrosine Kinase Inhibitor library is ideal database for high-throughput screening (HTS) and cell based high-content screening (HCS).

  • Ubiquitination Compound Library

    A unique collection of 146 small molecules for Ubiquitination related research.

×

大阪市内で「G20サミット」が開催されることに伴い、大阪府内で大規模な交通規制が行われる影響で、6月26日（水）から7月1日（月）までの間、下記地域へ出荷が行えなくなります。
対象地域
大阪府（全域）、兵庫県（芦屋市、尼崎市、伊丹市、西宮市）
上記地域より西の地域につきましては納期の遅延が予想されます。
また、国際便も遅延が予想されているため国内在庫がない製品の納期が一週間程度遅れる可能性がございます。
ご不便をおかけいたしますが、宜しくお願い申し上げます。